, CI = confidence interval
, GnRH = gonadotrophin-releasing hormone
A prospective, randomised, investigator-blind, controlled, clinical study on the clinical efficacy and tolerability of two highly purified hMG preparations administered subcutaneously in women undergoing IVF, Gynecol. Endocrinol, vol.29, pp.695-699, 2013. ,
A systematic review of tests predicting ovarian reserve and IVF outcome, Hum. Reprod. Update, vol.12, pp.685-718, 2006. ,
Le rapport médical et scientifique de l'assistance médicale à la procréation et de la génétique humaines en France. Activité d'Assistance Médicale à la Procréation, 2016. ,
Model' versus 'everyday' patients: can randomized controlled trial data really be applied to the clinic?, Reprod. Biomed, vol.34, pp.274-279, 2017. ,
Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech, Clinics (Sao Paulo), vol.69, pp.279-293, 2014. ,
A randomized controlled trial comparing the efficacy and safety of two HMG preparations gaining their LH bioactivity from different HCG sources, Reprod. Biomed. Online, vol.35, pp.17-27, 2017. ,
Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients, Fertil. Steril, vol.109, pp.968-979, 2018. ,
The role of LH in ovarian stimulation, Curr Pharm Biotechnol, vol.13, pp.409-416, 2012. ,
Forty years of IVF, Fertil. Steril, vol.110, pp.185-324, 2018. ,
Management Strategies for POSEIDON's Group 1, Front Endocrinol (Lausanne), vol.10, p.679, 2019. ,
Real-World Evidence of Treatment Effects: The Useful and the Misleading, Clin. Pharmacol. Ther, vol.106, pp.43-44, 2019. ,